look, I can only comment on the skin diagnosis part as discussed in the audio interview. I know of many companies trying to use AI to diagnose skin conditions (and have invested in two) and it is a lot lot more difficult than it seems (even though the skin is just sitting there waiting to be photographed).
1. quality of images is extremely difficult to standardize - distance, skin tone, focus, size
2. what is the gold standard?
3. Does one need diagnosis or just OK versus go see doctor?
- Forums
- ASX - By Stock
- AHI
- MyFiziq (ASX:MYQ) is poised to disrupt the $45B medical imaging market
MyFiziq (ASX:MYQ) is poised to disrupt the $45B medical imaging market, page-30
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AHI (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AHI (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online